Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 262

1.

An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases.

Zeng L, Chow E, Zhang L, Tseng LM, Hou MF, Fairchild A, Vassiliou V, Jesus-Garcia R, Alm El-Din MA, Kumar A, Forges F, Chie WC, Bedard G, Bottomley A.

Support Care Cancer. 2012 Dec;20(12):3307-13. doi: 10.1007/s00520-012-1484-x. Epub 2012 May 6.

PMID:
22562607
2.

Quality of life after palliative radiation therapy for patients with painful bone metastases: results of an international study validating the EORTC QLQ-BM22.

Zeng L, Chow E, Bedard G, Zhang L, Fairchild A, Vassiliou V, Alm El-Din MA, Jesus-Garcia R, Kumar A, Forges F, Tseng LM, Hou MF, Chie WC, Bottomley A.

Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):e337-42. doi: 10.1016/j.ijrobp.2012.05.028. Epub 2012 Jul 3.

PMID:
22763028
3.

International field testing of the reliability and validity of the EORTC QLQ-BM22 module to assess health-related quality of life in patients with bone metastases.

Chow E, Nguyen J, Zhang L, Tseng LM, Hou MF, Fairchild A, Vassiliou V, Jesus-Garcia R, Alm El-Din MA, Kumar A, Forges F, Chie WC, Bottomley A; European Organization for Research Treatment of Cancer Quality of Life Group..

Cancer. 2012 Mar 1;118(5):1457-65. doi: 10.1002/cncr.26410. Epub 2011 Aug 11.

4.

Minimal important differences in the EORTC QLQ-C30 in patients with advanced cancer.

Bedard G, Zeng L, Zhang L, Lauzon N, Holden L, Tsao M, Danjoux C, Barnes E, Sahgal A, Poon M, Chow E.

Asia Pac J Clin Oncol. 2014 Jun;10(2):109-17. doi: 10.1111/ajco.12070. Epub 2013 Apr 1.

PMID:
23551530
5.

Comparison of the EORTC QLQ-BM22 and the FACT-BP for assessment of quality of life in cancer patients with bone metastases.

Popovic M, Nguyen J, Chen E, Di Giovanni J, Zeng L, Chow E.

Expert Rev Pharmacoecon Outcomes Res. 2012 Apr;12(2):213-9. doi: 10.1586/erp.11.99.

PMID:
22458622
6.

The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22.

Chow E, Hird A, Velikova G, Johnson C, Dewolf L, Bezjak A, Wu J, Shafiq J, Sezer O, Kardamakis D, Linden Yv, Ma B, Castro M, Arnalot PF, Ahmedzai S, Clemons M, Hoskin P, Yee A, Brundage M, Bottomley A; EORTC Quality of Life Group.; Collaboration for Cancer Outcomes Research and Evaluation..

Eur J Cancer. 2009 May;45(7):1146-52. doi: 10.1016/j.ejca.2008.11.013. Epub 2008 Dec 25.

PMID:
19097882
7.

A prospective study validating the EORTC QLQ-BM22 bone metastases module in patients with painful bone metastases undergoing palliative radiotherapy.

Raman S, Ding K, Chow E, Meyer RM, Nabid A, Chabot P, Coulombe G, Ahmed S, Kuk J, Dar AR, Mahmud A, Fairchild A, Wilson CF, Wu JS, Dennis K, DeAngelis C, Wong RK, Zhu L, Brundage M.

Radiother Oncol. 2016 May;119(2):208-12. doi: 10.1016/j.radonc.2016.04.035. Epub 2016 May 3.

PMID:
27157890
8.

[The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire for Japanese patients with bone metastases--The Japanese version of the EORTC QLQ-BM22].

Satoh T, Kobayashi K, Hori T, Iida S, Sato A, Ishiguro H, Chow E, Shimozuma K.

Gan To Kagaku Ryoho. 2010 Aug;37(8):1507-12. Japanese.

PMID:
20716876
9.

Comparison of the EORTC QLQ-BM22 and the BOMET-QOL quality of life questionnaires in patients with bone metastases.

Bedard G, Zeng L, Poon M, Lam H, Lauzon N, Chow E.

Asia Pac J Clin Oncol. 2014 Jun;10(2):118-23. doi: 10.1111/ajco.12064. Epub 2013 Apr 1.

PMID:
23551978
10.

Minimal clinically important differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL modules in patients with bone metastases undergoing palliative radiotherapy.

Raman S, Ding K, Chow E, Meyer RM, Nabid A, Chabot P, Coulombe G, Ahmed S, Kuk J, Dar AR, Mahmud A, Fairchild A, Wilson CF, Wu JSY, Dennis K, DeAngelis C, Wong RKS, Zhu L, Brundage M.

Qual Life Res. 2016 Oct;25(10):2535-2541. doi: 10.1007/s11136-016-1308-4. Epub 2016 May 2.

PMID:
27138964
11.

Minimal clinically important differences in the EORTC QLQ-BN20 in patients with brain metastases.

Wong E, Zhang L, Kerba M, Arnalot PF, Danielson B, Tsao M, Bedard G, Thavarajah N, Cheon P, Danjoux C, Pulenzas N, Chow E.

Support Care Cancer. 2015 Sep;23(9):2731-7. doi: 10.1007/s00520-015-2637-5. Epub 2015 Feb 10.

PMID:
25663577
12.

Understanding the EORTC QLQ-BM22, the module for patients with bone metastases.

Chow E, Bottomley A.

Expert Rev Pharmacoecon Outcomes Res. 2009 Oct;9(5):461-5. doi: 10.1586/erp.09.50.

PMID:
19817529
14.

Validation of the Polish version of the EORTC QLQ-BM22 module for the assessment of health-related quality of life in patients with bone metastases.

Püsküllüoğlu M, Tomaszewski KA, Bottomley A, Holden L, Tomaszewska IM, Głowacki R, Bereza K, Golec EB, Chow E, Krzemieniecki K.

Qual Life Res. 2014 Mar;23(2):527-32. doi: 10.1007/s11136-013-0486-6. Epub 2013 Aug 3.

PMID:
23912854
15.

EORTC QLQ-C15-PAL quality of life scores in patients with advanced cancer referred for palliative radiotherapy.

Caissie A, Culleton S, Nguyen J, Zhang L, Zeng L, Holden L, Dennis K, Chan E, Jon F, Tsao M, Danjoux C, Sahgal A, Barnes E, Koo K, Chow E.

Support Care Cancer. 2012 Apr;20(4):841-8. doi: 10.1007/s00520-011-1160-6. Epub 2011 May 3.

PMID:
21538099
16.

Validation of the Chinese version of EORTC QLQ-BM22 in patients with bone metastases.

Zhang L, Su YJ, Chen JY, Liao ZC, Luo ZQ, Xie SM, Zhang J, Lin YS, Guo H, Sun WL, Pekbay B, Miller AR, Luo L, Rui YH, Li MH, Wang CL.

Support Care Cancer. 2016 Mar;24(3):1019-24. doi: 10.1007/s00520-015-2870-y. Epub 2015 Aug 6.

PMID:
26245496
17.

Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL.

Caissie A, Nguyen J, Chen E, Zhang L, Sahgal A, Clemons M, Kerba M, Arnalot PF, Danjoux C, Tsao M, Barnes E, Holden L, Danielson B, Chow E.

Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1238-45. doi: 10.1016/j.ijrobp.2011.09.025. Epub 2011 Dec 13.

PMID:
22172909
18.

EORTC QLQ-BM22 quality of life evaluation and pain outcome in patients with bone metastases from breast cancer treated with zoledronic acid.

Yeh DC, Chen DR, Chao TY, Chen SC, Wang HC, Rau KM, Feng YH, Chang YC, Lee KD, Ou-Yang F, Kuo WH, Chang KJ, Lin YC, Tseng LM, Hou MF.

In Vivo. 2014 Sep-Oct;28(5):1001-4.

PMID:
25189922
19.

Predictive factors for overall quality of life in patients with advanced cancer.

Cramarossa G, Chow E, Zhang L, Bedard G, Zeng L, Sahgal A, Vassiliou V, Satoh T, Foro P, Ma BB, Chie WC, Chen E, Lam H, Bottomley A.

Support Care Cancer. 2013 Jun;21(6):1709-16. doi: 10.1007/s00520-013-1717-7. Epub 2013 Jan 22.

PMID:
23338229
20.

EORTC QLQ-BM22 and QLQ-C30 quality of life scores in patients with painful bone metastases of prostate cancer treated with strontium-89 radionuclide therapy.

Kurosaka S, Satoh T, Chow E, Asano Y, Tabata K, Kimura M, Tsumura H, Matsumoto K, Ishiyama H, Inoue Y, Hayakawa K, Baba S.

Ann Nucl Med. 2012 Jul;26(6):485-91. doi: 10.1007/s12149-012-0598-z. Epub 2012 Apr 3.

PMID:
22477263

Supplemental Content

Support Center